Viking Global Investors Portfolio holdings
AUM
$34.6B
1-Year Return
30.14%
This Quarter Return
+9.58%
1 Year Return
+30.14%
3 Year Return
+120.76%
5 Year Return
+143.03%
10 Year Return
+428.26%
AUM
$27.4B
AUM Growth
+$1.42B
(+5.4%)
Cap. Flow
-$384M
Cap. Flow
% of AUM
-1.4%
Top 10 Holdings %
Top 10 Hldgs %
38.58%
Holding
105
New
23
Increased
21
Reduced
25
Closed
22
Top Buys
| 1 |
Visa
V
|
+$964M |
| 2 |
Bank of America
BAC
|
+$792M |
| 3 |
Spotify
SPOT
|
+$775M |
| 4 |
Flutter Entertainment
FLUT
|
+$604M |
| 5 |
US Bancorp
USB
|
+$376M |
Top Sells
| 1 |
Amazon
AMZN
|
+$976M |
| 2 |
Dollar Tree
DLTR
|
+$727M |
| 3 |
HDFC Bank
HDB
|
+$563M |
| 4 |
Las Vegas Sands
LVS
|
+$560M |
| 5 |
Netflix
NFLX
|
+$516M |
Sector Composition
| 1 | Financials | 24.75% |
| 2 | Technology | 24.45% |
| 3 | Healthcare | 16.01% |
| 4 | Consumer Discretionary | 11.68% |
| 5 | Industrials | 7.03% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
51
Zscaler
ZS
$44.1B
| $145M | 0.53% |
+847,771
| New | +$145M |
|
52
Integer Holdings
ITGR
$3.55B
| $144M | 0.53% |
1,110,517
-1,262
| -0.1% | -$164K |
|
53
Teva Pharmaceuticals
TEVA
$22.9B
| $136M | 0.5% |
+7,567,533
| New | +$136M |
|
54
Eli Lilly
LLY
$677B
| $135M | 0.49% |
152,038
+7,863
| +5% | +$6.97M |
|
55
NewAmsterdam Pharma
NAMS
$2.72B
| $133M | 0.49% |
8,024,565
| – | – |
|
56
Oscar Health
OSCR
$5B
| $131M | 0.48% |
6,172,132
+244,094
| +4% | +$5.18M |
|
57
Comcast
CMCSA
$122B
| $129M | 0.47% |
+3,092,685
| New | +$129M |
|
58
Equitable Holdings
EQH
$16.2B
| $128M | 0.47% |
3,050,262
-2,809,285
| -48% | -$118M |
|
59
3M
MMM
$84.1B
| $115M | 0.42% |
840,751
-803,394
| -49% | -$110M |
|
60
Ameriprise Financial
AMP
$46.9B
| $114M | 0.42% |
243,055
-665,965
| -73% | -$313M |
|
61
Tesla
TSLA
$1.28T
| $114M | 0.42% |
+436,272
| New | +$114M |
|
62
Standard BioTools
LAB
$493M
| $113M | 0.41% |
58,651,170
| – | – |
|
63
Rogers Communications
RCI
$19.3B
| $109M | 0.4% |
+2,701,058
| New | +$109M |
|
64
Regal Rexnord
RRX
$9.22B
| $105M | 0.38% |
630,121
-493,042
| -44% | -$81.8M |
|
65
CoStar Group
CSGP
$36.8B
| $95.1M | 0.35% |
+1,261,195
| New | +$95.1M |
|
66
Boston Scientific
BSX
$152B
| $81.1M | 0.3% |
+967,210
| New | +$81.1M |
|
67
Pharvaris
PHVS
$1.49B
| $67.7M | 0.25% |
3,653,310
| – | – |
|
68
Immunovant
IMVT
$2.82B
| $66.2M | 0.24% |
2,320,902
| – | – |
|
|
LBPH
69
DELISTED
Longboard Pharmaceuticals, Inc. Common Stock
LBPH
| $65.6M | 0.24% |
1,969,041
+310,079
| +19% | +$10.3M |
|
70
Li Auto
LI
$24.8B
| $53.2M | 0.19% |
+2,075,279
| New | +$53.2M |
|
71
Regeneron Pharmaceuticals
REGN
$59.4B
| $52.4M | 0.19% |
+49,870
| New | +$52.4M |
|
72
Zai Lab
ZLAB
$3.65B
| $47.1M | 0.17% |
1,949,937
-87,437
| -4% | -$2.11M |
|
73
Carvana
CVNA
$50B
| $46.9M | 0.17% |
269,088
-284,533
| -51% | -$49.5M |
|
74
Viking Therapeutics
VKTX
$2.79B
| $45.7M | 0.17% |
721,926
-632,524
| -47% | -$40M |
|
75
Oric Pharmaceuticals
ORIC
$1.05B
| $41M | 0.15% |
4,000,000
| – | – |
|